Chennai-based medical diagnostics company Trivitron Healthcare is planning to invest Rs100 crore in the next 12-18 months, which will go into creating new manufacturing facilities and rolling out new products.

Through nine manufacturing facilities spread across India, Finland, and Turkey, Trivitron manufactures products across IVD segment, imaging products (ultrasound/X-ray/X-ray accessories), radiation protection products, intensive care (ICU), operation theatre, dialysis, and newborn screening products.

The company will be adding two more manufacturing facilities, one in Chennai to make operation room equipment with an investment of Rs15 crore.

Another facility will come up in Pune which will make X-ray equipment. The company is waiting for approvals for this facility. In the coming 1-2 years, Trivitron plans to develop a series of new products that will include point-of-care devices, self-testing devices for thyroid and other disorders and deficiencies.